Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India

BACKGROUND: Glycopeptides such as vancomycin are frequently the antibiotics of choice for the treatment of infections caused by methicillin resistant Staphylococcus aureus (MRSA). For the last 7 years incidence of vancomycin intermediate S. aureus and vancomycin resistant S. aureus (VISA and VRSA re...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwari, Hare Krishna, Sen, Malay Ranjan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634751/
https://www.ncbi.nlm.nih.gov/pubmed/17067393
http://dx.doi.org/10.1186/1471-2334-6-156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634751/
https://www.ncbi.nlm.nih.gov/pubmed/17067393
http://dx.doi.org/10.1186/1471-2334-6-156

Ejemplares similares